Cite
HARVARD Citation
Aggarwal, N. et al. (2023). Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase. International journal of infectious diseases. pp. 310-317. [Online].